Alexis Guédon: Cardiovascular Risk Profiles and Outcomes in Patients With Giant Cell Arteritis
Alexis Guédon, Junior Deputy Editor at the European Journal of Preventive Cardiology, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“I’m very happy to announce that our latest research article has just been published online ahead of print in the European Journal of Preventive Cardiology!
In this large nationwide cohort study, we examined the cardiovascular risk profiles and outcomes of patients with Giant Cell Arteritis (GCA) compared to matched control populations. Our findings highlight significantly increased risks of MACE, aortic, peripheral arterial, and visceral artery events in GCA patients – underscoring the critical importance of cardiovascular risk management and inflammation control in this population.
Key insights include:
- GCA is associated with elevated risk of major vascular complications.
- Disease activity is associated with major adverse cardiovascular events, highlighting the role of systemic inflammation.
Many thanks to all co-authors and collaborators who made this work possible!
Article: Cardiovascular risk among Giant cell arteritis patients
Authors: Alexis F Guedon, Olivier Espitia, Maxime Beydon, Etienne Ghrenassia, Tristan Mirault, Emmanuel Messas, Florence Tubach, Raphaèle Seror, Franck Boccara, Ariel Cohen, Ruth Frikke-Schmidt, Børge Grønne Nordestgaard, Azeddine Dellal, Olivier Fain, Arsène Mekinian, Fabrice Carrat
Read the Full Article on European Journal of Preventive Cardiology”

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 19, 2026, 14:17Abdul Mannan: What Exactly Is a Platelet?
-
Sep 19, 2026, 13:39Keisuke Goda: Decoding Platelet Phenotypes in COVID-19 With Optofluidic Imaging
-
Sep 19, 2026, 13:30Targeted Thrombolysis Beyond tPA
-
Sep 19, 2026, 13:21Paul Armstrong: From Summer Studentship to Young Researcher
-
Sep 19, 2026, 13:06Rabiya Masood: Breaking the Cycle of Thalassemia Through Screening
-
Sep 19, 2026, 10:52Consuela A. Albright: The Critical Role of Black Blood Donors in Sickle Cell Treatment
-
Sep 19, 2026, 10:47Amber Yates: Inside Agios’ Partnership with the Sickle Cell Community
-
Sep 19, 2026, 10:46Anton Farkas: Mechanical Thrombectomy for Acute PE in Early Pregnancy
-
Sep 19, 2026, 10:40Marjolein Smidt: ASH Raises Ferritin Thresholds for Iron Deficiency